192 related articles for article (PubMed ID: 6419355)
1. [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin].
López Fernández MF; Batlle Fonrodona FJ; Ginsberg MH; Ruggeri ZM; Zimmerman TS
Sangre (Barc); 1983; 28(4):439-49. PubMed ID: 6419355
[No Abstract] [Full Text] [Related]
2. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
[TBL] [Abstract][Full Text] [Related]
3. Some immunofluorescent observations on factor VIII/von Willebrand factor in dogs.
Potter EV; Shaughnessy MA; Green D
Thromb Haemost; 1980 Oct; 44(2):56-61. PubMed ID: 6779399
[TBL] [Abstract][Full Text] [Related]
4. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
[TBL] [Abstract][Full Text] [Related]
5. Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.
Koutts J; Walsh PN; Plow EF; Fenton JW; Bouma BN; Zimmerman TS
J Clin Invest; 1978 Dec; 62(6):1255-63. PubMed ID: 311783
[TBL] [Abstract][Full Text] [Related]
6. [Liberation of platelet factor 4 during the platelet aggregation induced by ADP, thrombin and collagen fibres (author's transl)].
Domingo-Albós A; Doménech-Mateu D; Castillo-Cofiño R
Rev Esp Fisiol; 1973 Mar; 29(1):11-5. PubMed ID: 4749041
[No Abstract] [Full Text] [Related]
7. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction--expression of acute phase reaction or index of vascular endothelium damage?
Giustolisi R; Musso R; Cacciola E; Cacciola RR; Russo M; Petralito A
Thromb Haemost; 1984 Jul; 51(3):408. PubMed ID: 6437008
[No Abstract] [Full Text] [Related]
8. [Von Willebrand disease--a variation with an aberrant multimeric structure].
Batlle Fonrodona J; López Fernández MF; Fernández Villamor A; López Berges C; Lasierra Cirujeda J; López Borrasca A
Sangre (Barc); 1985; 30(2):146-53. PubMed ID: 3925572
[No Abstract] [Full Text] [Related]
9. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor can substitute for plasma fibrinogen in ADP-induced platelet aggregation.
Timmons S; Hawiger J
Trans Assoc Am Physicians; 1986; 99():226-35. PubMed ID: 3496699
[No Abstract] [Full Text] [Related]
11. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
Yoshioka A
Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
[No Abstract] [Full Text] [Related]
12. Factor VIII/von Willebrand factor.
Zimmerman TS; Ruggeri ZM; Fulcher CA
Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
[No Abstract] [Full Text] [Related]
13. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases].
Shinmyozu K; Maruyama Y; Ohkatsu Y; Maruyama I; Igata A
Rinsho Shinkeigaku; 1983 Feb; 23(2):172-9. PubMed ID: 6407797
[No Abstract] [Full Text] [Related]
14. The in vitro association of antihemophilic factor and von Willebrand factor.
Zucker MB; Soberano ME; Johnson AJ; Fulton AJ; Kowalski S; Adler M
Thromb Haemost; 1983 Feb; 49(1):37-41. PubMed ID: 6405497
[No Abstract] [Full Text] [Related]
15. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
Orthner CL
J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
Furlan M; Perret BA; Beck EA
Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
[TBL] [Abstract][Full Text] [Related]
17. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
18. Electroblotting of factor VIII/von Willebrand factor multimers after electrophoresis in SDS-agarose gel, discontinuous buffer system.
Batlle J; López Fernández MF; López Berges C; López Borrasca A
Br J Haematol; 1983 Sep; 55(1):195-6. PubMed ID: 6411111
[No Abstract] [Full Text] [Related]
19. [Platelet aggregation and von Willebrand's factor in 32 insulin-dependent diabetics. Value of the measurement of filtration pressure in the presence of ADP].
Prost-Dvojakovic RJ; Lecrubier C; Lanoe R; Batchvarova V; Samama M
Journ Annu Diabetol Hotel Dieu; 1976 May; ():239-47. PubMed ID: 1087675
[No Abstract] [Full Text] [Related]
20. Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/VWF.
Cockburn CG; de Beaufre-Apps RJ; Wilson J; Hardisty RM
Thromb Res; 1981 Feb; 21(3):295-309. PubMed ID: 6454278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
